Recombinant calcium channel is recognized by Lambert-Eaton myasthenic syndrome antibodies

Neurology

Volumn 54, Issue 3, 2000, Pages 757-759

  Iwasa, Kazuo ^a   Takamori, Masaharu ^b   Komai, Kiyonobu ^a   Mori, Yasuo ^c  

^a KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

^b Kanazawa Nishi Hospital   (Japan)

^c NATIONAL INSTITUTE FOR PHYSIOLOGICAL SCIENCES   (Japan)

Author keywords

Autoimmunity; Lambert Eaton myasthenic syndrome; Neuromuscular transmission; P Q type voltage gated calcium channel; Small cell lung carcinoma

Indexed keywords

AUTOANTIBODY; CALCIUM CHANNEL; PROTEIN SUBUNIT; RECOMBINANT PROTEIN;

ANTIGEN RECOGNITION; ARTICLE; AUTOIMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; EATON LAMBERT SYNDROME; HUMAN; IMMUNOBLOTTING; LUNG SMALL CELL CANCER; NEUROMUSCULAR TRANSMISSION; PRIORITY JOURNAL; SEROLOGY;

EID: 0034620565     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.54.3.757     Document Type: Article

References (10)

1. Lennon VA, Kryzer TJ, Griesmann GE, et al. Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes. N Engl J Med 1995;332:1467-1474.
2. Motomura M, Lang B, Johnston I, Palace J, Vincent A, Newsom-Davis J. Incidence of serum anti-P/Q-type and anti-N-type calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome. J Neurol Sci 1997;147:35-42.
3. Mori Y, Friedrich T, Kim M-S, et al. Primary structure and functional expression from complementary DNA of a brain calcium channel. Nature 1991;350:398-402.
4. Takamori M, Iwasa K, Komai K. Antibodies to synthetic peptides of the α1A subunit of the voltage-gated calcium channel in Lambert-Eaton myasthenic syndrome. Neurology 1997;48: 1261-1265.
5. Ellinor PT, Zhang J-F, Home WA, Tsien RW. Structural determinants of the blockade of N-type calcium channels by a peptide neurotoxin. Nature 1994;372:272-275.
6. 2+ interactions. Neuron 1995;15:1121-1132.
7. 2+ channel function and drug action. Trends Pharmacol Sci 1995;16:43-49.
8. O'Neill JH, Murray NM, Newsom-Davis J. The Lambert-Eaton myasthenic syndrome. A review of 50 cases. Brain 1988;111:577-596.
9. Komai K, Iwasa K, Takamori M. Calcium channel peptide can cause an autoimmune-mediated model of Lambert-Eaton myasthenic syndrome in rats. J Neurol Sci 1999;166:126-130.
10. Lang B, Waterman S, Pinto A, et al. The role of autoantibodies in Lambert-Eaton myasthenic syndrome. Ann NY Acad Sci 1997;841:596-605.